Fulcrum Therapeutics Inc.

FULC | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.80

+$0.04 (+1.06%)

At close: Sep 21, 2026, 4:00 PM ET

$3.80

$0 (0.00%)

After-hours: Sep 21, 2026, 7:56 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $286.88M

Enterprise Value $-23.63M

Beta 3.00

Average Volume 2.24M

Shares Outstanding (Diluted) 76.26M

Shares Change YoY 21.94%

Institutional Ownership 94.10%

Exchange NASDAQ

ISIN US3596161097

Price Performance

Price Change 1M -1.0%

Price Change 3M -1.3%

Price Change 6M -45.6%

Price Change YTD -65.2%

Price Change 1Y -49.0%

Price Change 3Y -8.9%

Price Change 5Y -86.2%

1M CAGR (ann.) -0.3%

1Y CAGR (ann.) -48.6%

5Y CAGR (ann.) -32.4%

All-Time CAGR -16.3%

Valuation

PE Ratio -3.14

Forward PE N/A

PEG Ratio -8.20

Forward PEG 0.04

PS Ratio N/A

Forward PS 0.80

PB Ratio 0.93

P/FCF Ratio -4.38

P/Adj. FCF Ratio -3.64

P/OCF Ratio -4.42

EV/Sales N/A

EV/EBIT 0.40

EV/EBITDA 0.27

EV/FCF 0.36

Earnings Yield -31.8%

FCF Yield -22.8%

Adj. FCF Yield -27.5%

Financial Health

Net Cash $313.56M

Total Debt $5.28M

Cash & Short-Term Investments $318.84M

Total Assets $323.95M

Current Ratio 31.35

Quick Ratio 31.35

Debt / Equity Ratio 0.02

Debt / EBITDA -0.06

Debt / FCF -0.08

OCF / Debt -12.46

Interest Coverage 0.00

Altman Z-Score 10.78

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -20.5%

Returns

Return on Assets -26.2%

Return on Equity -28.5%

Return on Invested Capital -27.4%

Return on Capital Employed -27.6%

Return on Tangible Assets -26.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -16.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -46.4%

EPS CAGR 5Y 23.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y -55.8%

FCF CAGR 5Y 13.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 17

EPS Growth Next 3Y 32.2%

Revenue Growth Next 3Y N/A

Earnings Date Oct 28, 2026

EPS Estimate (next Q) -$0.11

EPS Growth Est (next Q) -64.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $3.60

Price Target Upside -5.3%

Cash Flow

Operating Cash Flow $-65.78M

Free Cash Flow $-66.14M

Adj. Free Cash Flow $-79.7M

FCF Per Share -$0.87

OCF Per Share -$0.86

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-14.33M

Operating Income $-96.05M

EBITDA $-87.1M

Net Income $-85M

EPS (Diluted) -$1.21

Revenue / Employee N/A

Profit / Employee $-9.44M

Employees 9